New method could aid Alzheimer's research by predicting risk before symptoms start

Researchers have developed a new method to identify people who are at greater genetic risk of developing Alzheimer’s disease before any symptoms appear—which could help speed creation of novel treatments. Manish Paranjpe of the Broad Institute of MIT and Harvard in Cambridge, Massachusetts, United States, and colleagues present these findings in the open-access journal PLOS Genetics on September 1.

This article was originally published on

You may also be interested in:

Read More:

Lawyers Lookup